KRM Ayurveda Limited (NSEI: KRMAYURVED)
Health Care · Pharmaceuticals · IN
Rs229.90
-4.86% today · +27.2% 1Y
Public summary
A free snapshot of KRM Ayurveda Limited, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app KRM Ayurveda Limited (NSEI: KRMAYURVED) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $51.99M.
Over the last twelve months the share price has gained 27.2%, trading between 156.15 and 343.95.
Tweenvest scores KRM Ayurveda Limited across four factors: quality 82/100, value 75/100. Its strongest factor is quality.
KRMAYURVED price history
Key figures
- Market cap
- $51.99M
- Revenue (TTM)
- $11.56M
- P/E
- 20.87
- EPS
- 9.46
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs343.95
- 52-week low
- Rs156.15
- Avg volume (3M)
- —
- Shares outstanding
- 21.26M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc.NasdaqCM: ELOX | $53.08M | $13.15 | +2.02% |
| Cinclus Pharma Holding AB (publ)OM: CINPHA | $53.06M | Skr11.52 | -0.52% |
| Haleos Labs LimitedNSEI: HALEOSLABS | $52.96M | Rs1,636.80 | +1.10% |
| Citi Pharma LimitedKASE: CPHL | $52.39M | PKRs63.42 | -0.20% |
| Daehan Nupharm Co.,Ltd.KOSDAQ: A054670 | $51.76M | ₩4,930.00 | -1.99% |
| AB Science S.A.ENXTPA: AB | $51.52M | €0.59 | -6.40% |
| Enzychem Lifesciences CorporationKOSDAQ: A183490 | $51.50M | ₩990.00 | -2.65% |
| Chi Sheng Pharma & Biotech Co., LtdTPEX: 4111 | $51.48M | NT$28.35 | 0.00% |